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The discovery of a form of chronic, low-grade systemic inﬂammation (“metaﬂammation”) linked with obesity, but also associated
with several lifestyle-related behaviours not necessarily causing obesity, suggests a re-consideration of obesity as a direct cause
of chronic disease and a search for the main drivers—or cause of causes. Factors contributing to this are considered here within
an environmental context, leading to the conclusion that humans have an immune reaction to aspects of the modern techno-
industrial environment, to which they have not fully adapted. It is suggested that economic growth—beyond a point—leads to
increases in chronic diseases and climate change and that obesity is a signal of these problems. This is supported by data from
Sweden over 200 years, as well as “natural” experiments in disrupted economies like Cuba and Nauru, which have shown a positive
health eﬀect with economic downturns. The eﬀect is reﬂected both in human health and environmental problems such as climate
change, thus pointing to the need for greater cross-disciplinary communication and a concept shift in thinking on prevention if
economic growth is to continue to beneﬁt human health and well-being.
1.Introduction
Obesity is currently pandemic, as are many of the chronic
diseases often associated with this (e.g., type 2 diabetes) [1].
However, attributing the rise in chronic diseases to obesity
does little to explain the true aetiology of the problem—
the “cause of the causes” [2], which lies in more distal
determining factors. This is indicated by recent ﬁndings that
suggest a more complicated aetiological role for obesity than
just a simple weight-disease association. The discovery of a
form of low-grade systemic inﬂammation associated with
obesity [3], as well as with other lifestyle and environmental
factors(e.g.,aspectsofnutrition,inactivity,inadequatesleep,
stress, depression, excessive alcohol intake, smoking, etc.
[4, 5]) only some of which are linked to obesity, suggests
that obesity may be just a marker of a type of environment
and accompanying human lifestyle, which is mediated by
aspects of the modern industrial environment to which
humans have had little time to adapt. Furthermore, it has
been shown, using the metaphor of inﬂammation, that
this environment, is a driver not just of biological, but of
ecological “disease,” manifest in excessive greenhouse gas
emissionsandpotentialclimatechange,aswellasobesityand
chronic disease [6].
In the current paper, which is proposed as a forum
for a broader discussion in prevention, this argument is
extended to consider the role of economic growth—beyond
a point euphemistically deﬁned as a “sweet spot” [7]—as
a signiﬁcant distal driver behind the development of high
population levels of obesity and chronic disease, as well
as potentiating factors for climate change. (It is important
here to recognize the distinction between economic growth,
which is the rate of increase in the market value of traded
goods and services as measured by Gross Domestic Product
(GDP), and which is widely used as the measure of progress
throughout the world, and economic development (which
can include desired improvements in renewable resources
and nontangible assets such as literacy levels and access
to heath care).) Although of undoubted beneﬁt to human
health and well-being in the early stages of development [8],
economic growth, like all monetary investment, reaches a
point, beyond which it begins to yield diminishing returns in
relation to aspects of health and the environment. The cur-
rent analysis outlines this and shows why. This is supported2 Advances in Preventive Medicine
by empirical data, which deﬁne more clearly the transition
stage [9] of developing economies such as that currently
existsinChinaandIndia.Thelinkbetweenmodernlifestyles,
chronic disease, and environmental damage heralds the
increasing need for a more dynamic discourse around the
concept of growth, within which obesity and climate change
have become “collateral damage” [7]. This now poses a
threat to long-term prosperity, for which interdisciplinary
solutions need to be urgently sought. In the meantime,
“stealth interventions” [10], which are health interventions
instigatedforanotherpurpose,butwhichhaveapositiveside
eﬀect in health, might need to be considered to buﬀer the
inevitablelong-termchangesrequiredinthemacroeconomic
system. The use of personal carbon allowances [6, 11]i s
discussed as an example of an immediate and relatively
painless option for doing this.
2. Obesity,Inﬂammation, andChronicDisease
Obesity has been associated with ill-health since the days of
Hippocrates who said that “.. sudden death is more common
in those who are naturally fat than in the lean”[ 12]. Recent
ﬁndings have modiﬁed this to associate diﬀerent fat stores
with disease, with particular emphasis on visceral adipose
tissue or VAT [13] and more recently, intrahepatic fat [14].
Yet whilst this has increased predictive capacity, there are still
reasons to suggest that obesity may be as much a marker of
an aberrant lifestyle or toxic environment leading to disease,
as a cause of disease in itself.
The discovery of a form of low-grade, systemic inﬂam-
mation, since called “metaﬂammation” [15], associated with
chronic disease outcomes, supports this. Originally thought
to be a causal link between obesity and chronic disease [3],
metaﬂammation has since been found to be associated with
a wide range of (largely) lifestyle-related and environmental
factors, characteristic of the modern industrial environment
[6]. These are often, but not always, related to obesity, as
shown by acute inﬂammatory reactions in the body before
obesity has had time to develop (such as in the case of acute
overnutrition or inactivity) or in some cases by the absence
of obesity in the presence of these lifestyle behaviours (such
as in the case of starvation, smoking, stress, inadequate
sleep, excessive exercise). A list of factors associated with
metaﬂammation, both in the presence and absence of
obesity, is shown in Figure 1. Dotted lines in Figure 1 denote
a connection between lifestyle or environmental stimulants
and metaﬂammation/chronic disease without necessarily
the mediation of obesity. Straight lines show a connection
through obesity.
In contrast to the large (e.g., hundredfold) acute defen-
sive reaction of classical inﬂammation, “metaﬂammation”
is characterised by a small (∼3-4-fold), but chronic and
systemic rise in proinﬂammatory markers [15], many of
which have now been identiﬁed that is from C-reactive
protein (CRP) at the proximal level, to NFkB at the distal
transcription level [16]. Anti-inﬂammatory markers indicate
the opposing action of antagonising the metaﬂammatory
process. These are less well known but adiponectin, leptin,
Smoking
Starvation
Diet
Over-
nutrition
Lifestyle
Inactivity
Pollution Over-
exercise
Stress/
depression
Inadequate
sleep
Obesity
Metaﬂammation
Environment
Drug use
Excess
alcohol
+ other mechanisms (e.g., oxidative stress, insulin resistance, etc)
Chronic (Noncommunicable) disease
Figure 1: Environmental and lifestyle “inducers” of metaﬂamma-
tion, showing both independent and dependant eﬀects through
obesity (from [4]).
and high-density lipoprotein (HDL) are amongst those that
have been identiﬁed to date [17].
A table of factors causing pro- and anti-inﬂammatory
responses based on research evidence is shown in Table 1.
From Table 1 it can be seen that a clear underlying
distinction between pro- and anti-inﬂammatory stimuli
is the length of time that humans, as a species, have
engaged in these activities. Stimuli causing an immune
inﬂammatory response on the left-hand side of the table
for example are those with a relatively recent introduc-
tion into human lifestyles, whereas those causing an anti-
inﬂammatory reaction on the right-hand side are those with
which humans have evolved over many millennia. It should
also be apparent that while some of those factors associated
with inﬂammation may cause obesity, this has not been
found to be a prerequisite for metaﬂammation, leading to
a previous conclusion that it is the lifestyle factors causing
obesity (overnutrition, inactivity), as well as other lifestyle
factors associated with the modern environment (poor diet,
excessive alcohol intake, inadequate sleep, stress, depression,
passive and active smoking, air pollution, etc.) rather than
obesityperse,whicharethelinkwithdiseaseoutcomes[4].It
is appropriate therefore to identify the driving factors behind
these changes to shift the focus on chronic disease aetiology
from obesity, to its more distal cause.
3. The Epidemiology of Chronic Disease
To cover the spectrum of causality, classical epidemiology
typically involves investigating not just the cause of a
disease, but the cause of that cause [2]. Based on the
evidence presented above, this would lead to diﬀerent
levels of causality from proximal (diet, exercise, etc.) to
medial (stress, anxiety, peer pressure, etc.) to distal causes
(societal/economic inﬂuences, “modernity,” etc.), with vastlyAdvances in Preventive Medicine 3
Table 1: Lifestyle and environmentally related metaﬂammatory
“inducers.” (For a detailed list of references see references [10, 11],
and at http://www.lifestylemedicine.net.au/health-information/
lifestyle-medicine-evidence-base/inﬂammation-database/index
.htm).
Proinﬂammatory Anti-Inﬂammatory
A. Lifestyle
Exercise
too little (inactivity)
too much
Nutrition
alcohol (excessive)
excessive energy intake
“fast food”/western style
diet
fat
saturated
trans fatty acids
high fat diet
high N6:N3 ratio
ﬁbre (low intake)
fructose
glucose
high glucose/GI foods
glycaemic load
glycaemic status
meat (domesticated)
salt
sugar sweetened drinks
starvation
Obesity/Weight gain
Smoking
Sleep deprivation
Stress/Anxiety/Depression/
“Burn out” “Unhealthy”
lifestyle
Exercise/Physical Activity/Fitness
“Healthy” obesity
Intensive lifestyle change
Nutrition
alcohol
capsaicin
cocoa/chocolate (dark)
dairy calcium
eggs
energy intake (restricted)
ﬁsh/ﬁsh oils
ﬁbre (high intake)
garlic
grapes/raisons
herbs and spices
lean game meats
low GI foods
low N6:N3 ratio
Mediterranean diet
fruits/vegetables
mono-unsaturated fats
nuts
olive oil
soy protein
tea/green tea
vinegar
Smoking cessation
Weight loss
B. Environment
Age
Air pollution
indoor/outdoor
Atmospheric CO2
Perceived organisational justice
(low)
“Sick building syndrome”
Second hand smoke
SE Status (low)
diﬀerent implications for potentially successful population-
level preventive interventions.
As stated above, the dichotomy between pro- and anti-
inﬂammatory stimuli shown in Table 1 would suggest the
time around the industrial revolution of the late 19th
Century as a historical cutoﬀ characterising the diﬀerence
between these stimuli. This also deﬁnes the beginnings of
the technoindustrial environment and the early stages of
exponential growth of human populations. Hence indus-
trialisation, and the economic and population growth
accompanying this, should be considered as a distal cause
of modern chronic disease. The fact that obesity in this
scenario is a marker, as well as a cause of disease, suggests an
interesting proposition thatobesity is collateraldamagefrom
the modern environment, which in turn, is closely associated
with human development, and more speciﬁcally, economic
growth over the last ∼200 years. Obesity and chronic disease,
then result from our inability—or unwillingness—to adjust
totheenvironmentemanatingfromeconomicadvancement,
beyond a point. Metaﬂammation represents the body’s
response to this through a low level immune reaction to the
lifestyle factors facilitated through such an environment.
4. Obesity,ChronicDisease, andEconomics
There is ample evidence to support the notion that while
economicdevelopmentisgenerallypositivelyassociatedwith
human health [8], this is not always the case, either over
the short-term, in relation to booms and recessions [18–20],
or over the long-term [21, 22]. It should be obvious, for
example, that as the measure of economic growth, that is
GDP, is determined by throughput, irrespective of outcome,
it is possible that contributors to GDP could be health
negative, or “illth” creating.(The term “illth” was ﬁrst coined
by the 19th Century English novelist John Ruskin (1857)
who recognised that in the economic discussions of value
of the time, no account had been taken of production of
objects that cause harm or are socially undesirable. Ruskin
referred to the outcome of those objects that are harmful
or socially undesirable but still have value in exchange as
“illth”.) Around 10% of GDP in developed countries, for
example, is made up of revenue from tobacco, alcohol, and
drug sales, many of which can have an adverse eﬀect on
human health (it is ironic that some cigarette manufacturers
also manufacture surgical equipment, thus catering for both
ends of the spectrum, making and doubling the beneﬁt for
GDP from smoking).
Of course, this has not always been the case, and hence
to be comprehensive, any proposition of a link between
economic growth and health needs to be dynamic. Growth
has unarguably been positively related to human longevity
and health overall, as witnessed by the big improvements
in longevity in developed countries since the industrial
revolution [8]. In developing economies however there is
an “epidemiological transition” [23], where a switch occurs
from a high prevalence of infectious disease to a growing
prevalence of chronic diseases, after which mortality rates
continue to decrease (although at a decreasing rate), but
there is a growing increase in morbidity as reﬂected in
the measure of years of life spent with a disability (YLD)
component of disability adjusted life years (DALYs). The
point leading up to this has euphemistically been referred to
asa“sweetspot”inhumandevelopment,wherethisreﬂectsa
point of optimal returns [7]. In economic terms this reﬂects
the start of a point of diminishing marginal rates of return
from continued investment in the growth paradigm.
The recent work by Tapia Granados and others [22, 24]
has begun to objectify the point at which this might have
already occurred in relation to some aspects of human
health. In analysing Swedish mortality and economic data
from 1800 to 2000, Tapia Granados and Ionides [24]h a v e4 Advances in Preventive Medicine
shown the beginnings of a diminishing rate of returns on
the growth model in relation to mortality rates in the last
half of the 20th Century. This coincides, not unexpectedly,
with the levelling of improvements in health made from the
decrease in infectious diseases associated with development,
and the consequent increase in chronic diseases associated
with modern lifestyles, driven as they are by the modern
environment. It is this switch, from predominantly microbe-
related infectious disease, to lifestyle-related chronic disease,
and the consequent shift in the human immune reaction
fromanacuteresponsetoaninvadingorganism,toachronic
reaction to nonmicrobial, lifestyle-related “inducers” [25]
that diﬀerentiates the early from late stages of economic
development. This has been shown in several developing
societies and is currently being witnessed in China and India
in accelerated form.
Other support for the developing adverse eﬀects of
development, beyond a point, is gained from studying the
situation in reverse. Cuba, for example, was forced into
economic decline after Russia’s withdrawal in 1989 resulting
in a 1000kcal/day average decrease in food intake. The
following decade was characterised by an improvement in
many aspects of chronic disease; overall mortality decreased
by 20%, obesity was halved, and deaths from heart disease
reducedby35%andstrokeby18%[26].Onlycancers,which
could be expected to have a longer lag-time in relation to
causality, had not, at the time of study been aﬀected. Nauru,
a tiny island in the South Paciﬁc, whose economy was based
on superphosphate exported for fertilising the farm-lands
of Australia and New Zealand, is another example. After
exhaustion of its superphosphate supplies and consequent
economic slump in the 1990s, Nauruans have decreased
their obesity and diabetes levels dramatically from amongst
the highest rates in the world [27]. Similarly, Hodge et al.
[28] have shown the eﬀects of development on obesity in
villages in Papua-New Guinea. In quantifying measures of
“modernity” such as cars, TV, microwaves, etc., Hodge et
al. report a linear association between villages scoring high
on modernity and high on measures of obesity, which is at
least a marker, if not a determinant of chronic disease. In a
closer examination of causality of such changes, researchers
have found a link between lifestyles and disease. Using
postwarJapanasanexample,Tapia-Granadosandcolleagues
found that times of economic prosperity correspond to
increasedconsumptionoftobacco,alcohol,andsaturatedfat;
inactivity, work pressures, inadequate sleep, social isolation,
traﬃc injuries, and social isolation [29], all of which have
links with metaﬂammation and chronic disease [4].
From a diﬀerent perspective, negative developments in
environmental degradation, such as manifest in climate
change, also point to diminishing returns from unlim-
ited growth. Studies on carbon and other greenhouse gas
emissions, for example, show a highly positive association
between atmospheric concentration of these and economic
ﬂuctuations [30], as might be expected. In a comparative
analysis proposed recently [31], a converging causal hierar-
chyhasbeenproposedbetweenbiologicalandecologicaldis-
ruptions, which synthesises these eﬀects and metaphorically
ties them to “inﬂammation” (meta—versus ecoﬂammation),
as shown in Figure 2.
An awareness of the convergence of health, climate, and
macroeconomics gives rise to a need for consideration of all
three phenomena.
5.ManagingDiminishingReturns
It would be naive to propose the above argument as a reason
to cease economic growth, or even revert immediately to
a nongrowth, or steady-state economy. However, growing
environmental, and health issues—as well as the often-
unrecognised link between the two—make it important to
place the issue on the prevention agenda. Consideration of
the consequences of unfettered growth (both economic and
population growth—which helps to drive this), which were
raised in the 1970s [32], but then dismissed by religious,
political, and economic arguments in the 1980s, need to
be brought back to the fore within the context of human
and environmental health and well-being. Discussions about
climate change and environmental pollution, although cur-
rently based around technological growth as the potential
solution, cannot be divorced from notions of exponential
growth as a distal driver.
Immediate actions, which are within the realm of
political possibility, such as carbon emissions policies, both
corporate and personal, need to be expedited by health
and environmental experts, without ignoring the long-term
as well as short-term economic consequences. Corporate
carbon policies are already on the statutes in many countries
in one form or another and, if properly instituted, might be
expectedtohaveanimpactnotonlyontheenvironment,but
on health, through the increased cost of energy-dense, and
hence fattening, processed foods [6]. Yet corporate carbon
emissions make up only 40%–50% of total emissions, the
remainder being by individuals and households [33]. Hence
the need for a personal carbon emissions policy aimed at
reducing emissions from individuals and households. To
this end, a personal carbon trading (PCT) scheme has been
proposed by the Global Commons Institute in the UK
[34] and embellished by others [11, 35]. PCT might be
expected to increase personal energy expenditure (and hence
reduceobesitybychangingenergybalance)byreducingfossil
fuel usage. The system has been explained in more detail
elsewhere [35], with a trial of such a scheme proposed in
a “closed” environment of an island economy in the South
Paciﬁc [36].Thisisdesignedtotesttheeﬀectthisshouldhave
on attitudes to over-consumption, which, together with the
growth imperative, are the driving forces behind personal as
well as environmental “illth.”
6. Conclusion
In classic economic terms, body fat is an investment in the
future.Thisyieldshealthydividends(inthiscase,survival)—
toapoint,justasallgoodinvestments.Butbeyondthispoint,
diminishing rates of returns begin to decrease the value of
further investment. Body fat, to a level probably deﬁnedAdvances in Preventive Medicine 5
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Figure 2: Relational epidemiology between chronic disease and climate change.
by individual genetics, is a necessary and healthy source of
reserve energy. Recent ﬁndings suggest that while fat stays in
the fat cells, for which they are designed, this is not a cause
for concern. Only when lipid intolerant nonadipose organs
are not protected against lipid “spillover” during sustained
energy surplus does it become a problem [37]. In advanced
economies, the bulk of such an energy surplus comes from
the use of nonrenewable resources (fuel for transport and
eﬀort-saving devices, energy for production of energy-dense
foods and drinks), the combustion of which also leads to
greenhouses gas emissions. When these occur beyond a level
of equilibrium with sequestration, or the ability of the earth’s
sinks to soak this up (the ecological “sweet spot”), they build
up in the atmosphere, leading to ecological abnormalities
such as severe weather events, species extinction, and climate
change. The similarities between obesity and climate change,
although metaphorical, are thus apparent. In seeking the
driver of both, it is apparent that economic growth, beyond
the point forewarned by the early economists such as J. S.
Mill [38]asthatwheregrowthwouldneedtobemodiﬁed(as
“nothing can grow forever”), is the ultimate distal cause. As
summed up by one commentator: “Growth beyond maturity
is either obesity or cancer”[ 39]. And while this is now
becoming increasingly obvious amongst health scientists,
it is imperative to involve other disciplines—economists,
ecologists, politicians—in a discourse much broader than
that which is traditionally considered as encompassing
obesity and chronic disease prevention. Some initiatives are
beginning in this direction (i.e., see [40]). However much
more is likely to be required if human health and chronic
disease are to be progressively improved.
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